Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03277118 · ClinicalTrials.gov registry record
Quantifying Activity Using Wireless Wearable Technology
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 91
- Enrollment target
NCT03277118: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT03277118 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 91 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03277118 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
Wireless wearable devices (WWD) have been shown to be an effective means to measure patient activity and sleep-wake cycles in the ICU. However, no current studies involving WWD have demonstrated the ability of these devices to measure adverse outcomes, including delirium in critically ill patients. This study is unique because the investigators will implement monitoring with the WWD prior to extubation in the ICU to correctly measure first mobilization, as well as capture quality of sleep and episodes of delirium for the first five postoperative days.
Primary Outcome
Number of steps walked as measured by the Wireless Wearable Device
Interventions
- DEVICE Wireless Wearable Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2017-04-18 |
| Est. Completion | 2019-08-18 |
What the finished NCT03277118 record still lists
NCT03277118 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 91 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Wireless Wearable Device is the first listed.
NCT03277118 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03277118 about?
NCT03277118 is a clinical study titled "Quantifying Activity Using Wireless Wearable Technology". Wireless wearable devices (WWD) have been shown to be an effective means to measure patient activity and sleep-wake cycles in the ICU. However, no current studies involving WWD have demonstrated the ability of these devices to measure adverse outcomes, including delirium in critically ill patients. ...
What is the current status of trial NCT03277118?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2017-04-18. Estimated completion is 2019-08-18.
What interventions are being tested in trial NCT03277118?
The interventions under investigation include: Wireless Wearable Device (DEVICE).
Who is sponsoring clinical trial NCT03277118?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI